Business Wire

Smoke Free Sweden: EU’s Outdated Tobacco Strategy Is Failing and Costing Lives

6.11.2024 05:47:00 CET | Business Wire | Press Release

Share

New analysis of data by Smoke Free Sweden from the Europe Union’s leading research body reveals how the EU’s outdated tobacco control strategy is losing the war against smoking.

The landmark report by global public health experts reveals:

  • At current rates, the EU will not meet its ‘smoke free’ target for another 76 years.
  • Only the adoption of innovative solutions is significantly reducing the deadly toll of cigarettes in countries such as Sweden, which is on the brink of becoming smoke free.
  • Widespread resistance to safer alternatives in other nations has pushed the EU’s average smoking rate five times higher than Sweden’s.
  • Misguided restrictions on vapes have seen Estonia’s smoking rate soar by almost 40% in just three years.

Dr. Delon Human, lead author of the report Missing The Target, says: “It is time for the EU to recognise that restrictive policies on safer nicotine alternatives are costing lives.

“The data clearly show that countries prioritising harm reduction are achieving the smoke free goals that remain a distant dream for other member states."

“Only by embracing safer alternatives can the EU hope to reverse the current trends, save lives and achieve its long-awaited smoke free goal.”

Missing The Target uncovers fundamental flaws in the EU’s approach to achieving its goal of a 5% smoking rate by 2040 – the internationally recognised benchmark for ‘smoke free’ status.

Its findings paint a stark picture of the EU’s stalled progress:

A missed milestone - At its current rate, the EU will fall short of its 2040 smoke free goal by a staggering six decades. Smoking prevalence is only projected to drop below 5% by the year 2100, underscoring an urgent need for rethinking policies.

Strict regulations, rising smoking rates - In nations with severe restrictions on safer nicotine alternatives, cigarette smoking has not only persisted but, in some cases, increased. Estonia, where vape flavours are banned, has seen a staggering 38.89% rise in smoking - evidence that restrictive policies may be backfiring dramatically.

Sweden’s success story - Sweden is on the brink of achieving its smoke-free target an impressive 16 years ahead of the EU's goal. The key to its success lies in making safer nicotine alternatives accessible, acceptable and affordable. The widespread availability of alternatives such as snus, nicotine pouches and vapes has driven smoking rates down to near smoke-free levels.

Czechia’s progressive policies drive down smoking - Czechia has similarly embraced Tobacco Harm Reduction (THR) principles, fostering a liberal approach to vapes and other smokeless nicotine products. The country has witnessed a remarkable 23% drop in smoking rates over the past four years, showing that pragmatic policies can accelerate progress.

Report co-author Dr. Anders Milton, a physician and former president of the Swedish Medical Association, said: “The EU’s current tobacco control policy - relying heavily on taxation, smoking bans and product regulations - has produced only incremental reductions in smoking.

“A growing body of evidence points to the need for a modernised, evidence-based framework that embraces safer alternatives as part of a comprehensive THR strategy.”

ENDS

About Smoke Free Sweden

Smoke Free Sweden is a campaign encouraging other countries to follow the Swedish model of Tobacco Harm Reduction. Sweden is about to become the first ‘smoke free’ European country, with a smoking rate of below 5 percent. This remarkable achievement can be attributed to Sweden’s open attitude towards alternative products.

For more information on Sweden’s successful approach to becoming a smoke free nation, please visit www.smokefreesweden.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241105477767/en/

Contacts

Smoke Free Sweden
info@smokefreesweden.org

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 202512.3.2026 15:38:00 CET | Press Release

Today the Board of Directors of Reply S.p.A. [MTA, STAR: REY] approved the draft financial statement for the year 2025, which will be submitted for approval to the Shareholders’ Meeting to be held in first call in Turin on 23 April 2026. The Reply Group closed 2025 with a consolidated turnover of €2,483.6 million, an increase of 8.0% compared to €2,300.5 million in 2024. All indicators are positive for the period. Consolidated EBITDA was €467.6 million, an increase of 13.9% compared to €410.6 million at December 2024. EBIT, from January to December, was at €391.7 million, which is an increase of 18.5% compared to €330.4 million at December 2024. The Group net profit was at €250.9 million. In 2024, the corresponding value was €211.1 million. Following the results achieved in 2025, the Reply Board of Directors decided to propose to the next Shareholders’ Meeting a dividend distribution of €1.35 per share, which will be payable on 20 May 2026, with dividend date set on 18 May 2026 (record

LZE GmbH Introduces Fraunhofer’s RFicient® Technology to the Market12.3.2026 14:51:00 CET | Press Release

LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step for long-lasting, low-maintenance IoT products. LZE GmbH drives technology transfer to market: standard chip availability for close-to-production applications As a bridge between research and industry, LZE GmbH is making it easier for companies to access innovative technologies and helping them to quickly and reliably transform new developments into market-ready solutions. With RFicient®-IC (FH101RF), LZE is providing another high-tech product that comes directly from Fraunhofer research and can now be ordered in volume and integrated into close-to-production product development for t

Andersen Consulting Broadens Capabilities Through Collaboration with Acumen Learning12.3.2026 14:30:00 CET | Press Release

Andersen Consulting adds depth to its platform through a Collaboration Agreement with Acumen Learning, a U.S.-based firm specializing in business and financial acumen training for leadership development and sales performance. Founded in 2002, Acumen Learning works with Fortune 500 companies to enhance financial literacy, strategic thinking, and decision-making across all levels. Drawing from the principles in their best-selling books “Seeing the Big Picture” and “Business Acumen for Sales Success,” their programs equip leaders and teams to align decisions with corporate strategy, drive performance, and strengthen client relationships. Tailored for industries such as healthcare, energy, and technology, Acumen Learning empowers professionals to translate business knowledge into actionable impact. “At Acumen Learning, our mission is to empower individuals by creating business-savvy professionals who excel in their careers,” said CEO of Acumen Learning Kevin Cope. “Our courses pair practic

Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing12.3.2026 14:30:00 CET | Press Release

Owkin, the AI company on a mission to solve the complexity of biology, today announced the spin out of Waiv, formerly known as Owkin Dx. The move follows significant investor interest and positions Waiv to bring AI-powered precision testing for better identification of patients in the clinic and in clinical trials, to transform patient care. This follows on from the successful launch of Bioptimus, an Owkin incubated company, in February 2024. Waiv translates AI innovation into real-world clinical impact, developing tests that predict biomarkers and patient outcomes, including RlapsRisk BC for prognostic risk profiling. With multiple tests already in use in clinical settings, its deployment platform Destra, and collaborations with leading pharmaceutical companies, including MSD since 2023 for MSIntuit, Waiv is establishing itself as a leader in translational medical AI. Waiv leverages a decade of Owkin's foundational medical AI research, including access to an extensive patient data net

RQM+ Launches SMART Solutions Life Cycle Partnership Model12.3.2026 14:30:00 CET | Press Release

RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech companies across the entire product life cycle to help reduce risk from early development through post-market. “MedTech companies are navigating unprecedented complexity as regulatory expectations evolve, product innovation accelerates, and post-market expectations are expanding,” said John Potthoff, Ph.D., chief executive officer of RQM+. “SMART Solutions moves beyond traditional consulting by providing an integrated life cycle partnership that helps sponsors gain earlier clarity, reduce risk, and execute complex programs

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye